Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A>G
Iris A. L. Silva(University of Lisbon), Margarida D. Amaral(University of Lisbon), Jiunn‐Tyng Yeh(University of Missouri), Karl Kunzelmann(University of Regensburg), Carlos M. Farinha(University of Lisbon), Hugo M. Botelho(University of Lisbon), Violeta Railean(University of Lisbon), Iveta Valášková(Masaryk University), Luka A. Clarke(University of Lisbon), Sofia S. Ramalho(University of Lisbon), A. Holubová(Charles University), Tereza Doušová(Charles University), Tzyh‐Chang Hwang(National Yang Ming Chiao Tung University), Raquel Centeio(University of Lisbon)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
July 28, 2020
Cited by 13
Related Papers
Mechanical properties and wear behavior of light-cured packable composite resins
|Dental Materials|2000|367
CFTR modulator theratyping: Current status, gaps and future directions
|Journal of Cystic Fibrosis|2018|288
A New Optical 3-D Device for the Detection of Wear
|Journal of Dental Research|1997|237
The protein kinase A-regulated cardiac CI− channel resembles the cystic fibrosis transmembrane conductance regulator
|Nature|1992|173
Modulation of CFTR chloride channels by calyculin A and genistein
|American Journal of Physiology-Cell Physiology|1997|151